NFKB1 and glioblastoma: In contrast to the recently reported GBM viability decreasing and apoptosis enhancing co-treatment of NF-κB inhibitor BAY-7082 and TMZ [70], we did not detect any synergistic effects of PDTC and TMZ treatment.